Neviah Genomics Achieves Key Development Milestone for PropheTox™ Bioassay for Early Prediction of Drug-Induced Liver Toxicity and Secures Additional Financing
Neviah Genomics Achieves Key Development Milestone for PropheTox™ Bioassay for Early Prediction of Drug-Induced Liver Toxicity and Secures Additional Financing